Abstract
The prospective study by Steffens et al1 provides much-needed quality-of-life (QOL) data after cytoreductive surgery (CRS) for colorectal peritoneal metastases. Across 193 patients treated at 2 peritoneal malignancy units, QOL returned to baseline within 3 to 6 months postoperatively. A notable secondary outcome was the significantly different peritoneal cancer index (PCI) scores between the 2 countries, with a median of 5 in the United Kingdom versus a median of 10 in Australia.
| Original language | English |
|---|---|
| Pages (from-to) | 871-871 |
| Number of pages | 1 |
| Journal | Diseases of the Colon & Rectum |
| Volume | 69 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2026 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'International variation in colorectal peritoneal cancer index threshold'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver